ischemic heart disease
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: patient who was treated with percutaneous coronary intervention (PCI) and produced written informed consent in Tokyo Women's Medical University or University-related hospitals. Indication for PCI is in accordance with guidelines.
Exclusion criteria
Exclusion criteria: 1. patients who have intolerance of anti-platelets or anticoagulants scheduled to use 2. patients with severe allergic reactions against iodinated contrast 3. patients whose life expectancy of less than 12 months due to non-cardiac conditions at the enrollment 4. patients who are pregnant or during breast-feeding 5. patients who are regarded as ineligible for PCI at the conference with cardiac surgeons 6. inadequate patient judged by principal investigator
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| MACCE (Major adverse cardio- and cerebro-vascular event) | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. death from any cause 2. target vessel revascularizaiton 3. stent thrombosis 4. quality of life (QOL), depression 5. complications: catheter procedure-related/non-related | — |
Countries
Japan
Contacts
Tokyo Women's Medical University Department of Cardiology